Pathmanathan N, Balleine RL. Ki67 and proliferation in breast cancer. J Clin Pathol. 2013;66:512–6.

Article  CAS  PubMed  Google Scholar 

Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, et al. Sustained proliferation in cancer: therapeutic targets. Semin Cancer Biol. 2016;35:25–54.

Article  Google Scholar 

Wang Z. Regulation of cell cycle progression by growth factor-induced cell signaling. Cells. 2021;10(12):3327.

Brooks AJ, Putoczki T. Jak-stat signalling pathway in cancer. Cancers (Basel). 2020;12:1–3.

Article  Google Scholar 

Guo Y, Pan W, Liu S, Shen Z, Xu Y, Hu L. ERK/MAPK signalling pathway and tumorigenesis (Review). Exp Ther Med. 2020;19(3):1997–2007.

Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I - molecular mechanisms of activation and regulation. Front Immunol. 2015;6:1–30.

Article  Google Scholar 

Thurman JM, Laskowski J, Nemenoff RA, Complement. Cancer—A Dysfunctional Relationship? Antibodies. 2020;9:61.

PubMed  PubMed Central  Google Scholar 

Xie CB, Jane-Wit D, Pober JS. Complement Membrane Attack Complex: New Roles, Mechanisms of Action, and Therapeutic Targets. Am J Pathol. 2020;190:1138–50. https://doi.org/10.1016/j.ajpath.2020.02.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dho SH, Lim JC, Kim LK. Beyond the role of CD55 as a complement component. Immune Netw. 2018;18:1–13.

Article  Google Scholar 

Geller A, Yan J. The role of membrane bound complement regulatory proteins in tumor development and cancer immunotherapy. Front Immunol. 2019;10:1–13.

Ikeda Jichiro, Morii E, Liu Y, Qiu Y, Nakamichi N, Jokoji R, et al. Prognostic significance of CD55 expression in breast cancer. Clin Cancer Res. 2008;14:4780–6.

Article  CAS  PubMed  Google Scholar 

Shang Y, Chai N, Gu Y, Ding L, Yang Y, Zhou J, et al. Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer. Arch Pathol Lab Med. 2014;138:910–9.

Article  PubMed  Google Scholar 

Yin X, Shen C, Yin Y, Cai Z, Wang J, Zhao Z, et al. Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors. Onco Targets Ther. 2019;12:4703–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Zhang Z, Cao L, Lin J, Yang Z, Zhang X. A common CD55 rs2564978 variant is associated with the susceptibility of non-small cell lung cancer. Oncotarget. 2017;8:6216–21.

Article  PubMed  PubMed Central  Google Scholar 

Giannone G, Attademo L, Scotto G, Genta S, Ghisoni E, Tuninetti V, et al. Endometrial cancer stem cells: Role, characterization and therapeutic implications. Cancers (Basel). 2019;11:1–18.

Article  Google Scholar 

Hu X, li J, Fu M, Zhao X, Wang W. The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. Springer US; 2021. p. 6.

Thomas SJ, Snowden JA, Zeidler MP, Danson SJ. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer Nat Publishing Group. 2015;113:365–71.

CAS  Google Scholar 

Lo U, Chen Y, Cen J, Deng S, Luo J, Zhau H et al. The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer. Clin Transl Med. 2022;12(8):e978.

Touw IP, Palande K, Beekman R. Granulocyte Colony-Stimulating Factor Receptor Signaling. Implications for G-CSF Responses and Leukemic Progression in Severe Congenital Neutropenia. Hematol Oncol Clin North Am. 2013;27:61–73. https://doi.org/10.1016/j.hoc.2012.10.002

Article  PubMed  Google Scholar 

Zage PE, Whittle SB, Shohet JM. CD114: A new member of the neural Crest-Derived cancer stem cell marker family. J Cell Biochem. 2017;118:221–31.

Article  CAS  PubMed  Google Scholar 

Ji J, Wang XW. Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol. 2012;39:461–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaleli S, Deveci A, Gamze O, Eskiler G, Furkan K. Genistein enhances TLR3 – mediated apoptosis and immune signaling in breast cancer cells. Springer US; 2025.

Alobaedi OH, Talib WH, Basheti IA. Antitumor effect of thymoquinone combined with resveratrol on mice transplanted with breast cancer. Asian Pac J Trop Med. 2017;10:400–8. https://doi.org/10.1016/j.apjtm.2017.03.026

Article  CAS  PubMed  Google Scholar 

Kamisetti RR, Thymoquinone. A promising agent in the prevention of breast cancer international. J Res in. 2024;13:325–31.

Zenkov RG, Kirsanov KI, Ogloblina AM, Vlasova OA, Naberezhnov DS, Karpechenko NY et al. Effects of G-Quadruplex-Binding plant secondary metabolites on c-MYC expression. Int J Mol Sci. 2022;23(16):9209.

Riss TL, Moravec RA, Niles AL, Benink HA, Worzella TJ, Minor L. Cell Viability Assays. 2016;1–25. https://pubmed.ncbi.nlm.nih.gov/23805433/.

Cheng Y, Tang Q, Li Y, Zhang Y, Zhao C, Yan J et al. Folding/unfolding kinetics of G-quadruplexes upstream of the P1 promoter of the human BCL-2 oncogene. J Biol Chem [Internet]. © THE AUTHORS. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.; 2019;294:5890–5. Available from: https://doi.org/10.1074/jbc.RA119.007516

Spiegel J, Adhikari S, Balasubramanian S. Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions. Trends Chem. 2020;2:123–36. https://doi.org/10.1016/j.trechm.2019.07.002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kikin O, D’Antonio L, Bagga PS. QGRS mapper: A web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res. 2006;1:34.

Lopez C. RNA Extraction using Trizol. 2024;19–22.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-∆∆CT method. Methods. 2001;25(4):402–8.

Sule R, Rivera G, Gomes AV. Western blotting (immunoblotting): history. 2023;6205.

Dusell CD, Umetani M, Shaul PW, Mangelsdorf DJ, Mcdonnell DP. 27-Hydroxycholesterol is an endogenous selective Estrogen receptor modulator. Mol Endocrinol. 2015;22:65–77.

Hashemi M, Hesaraki M, Ramezankhani R, Yaghoubi SM, Shokouhian B, Piryaei A et al. Overexpression of KDM6A in Hepatoma Cells Induces Hepatocytic Differentiation and Attenuates Proliferation Rate, Colony Formation, and Migration Capacities. 2025;2025.

Khan MA, Tania M, Fu S, Fu J. Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget. 2017;8(31):51907–19.

Welte Y, Adjaye J, Lehrach HR, Regenbrecht CRA. Cancer stem cells in solid tumors: elusive or illusive? Cell Commun Signal. 2010;8:1–10.

Article  Google Scholar 

Sell S. On the stem cell origin of cancer. Am J Pathol. 2010;176:2584–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Badar F, Mahmood S, Faraz R, Yousaf A, ul Quader A, Asif H, et al. Epidemiology of breast cancer at the Shaukat Khanum memorial cancer hospital and research center, Lahore, Pakistan. J Coll Physicians Surg Pakistan. 2015;25:738–42.

Google Scholar 

Baig M, Sohail I, Altaf HN, Altaf OS. Factors influencing delayed presentation of breast cancer at a tertiary care hospital in Pakistan. Cancer Rep. 2019;2:1087–96.

Google Scholar 

Majeed I, Ammanuallah R, Anwar AW, Rafique HM, Imran F. Diagnostic and treatment delays in breast cancer in association with multiple factors in Pakistan. East Mediterr Heal J. 2021;27:23–32.

Article  Google Scholar 

Mansha M, Saleem M, Wasim M, Tariq M. Prevalence of known risk factors in women diagnosed with breast cancer at INMOL hospital, Lahore, Punjab. Asian Pac J Cancer Prev. 2016;17:563–8.

Article  PubMed  Google Scholar 

Zaheer S, Shah N, Maqbool SA, Soomro NM. Estimates of past and future time trends in age-specific breast cancer incidence among women in Karachi, pakistan: 2004–2025. BMC Public Health BMC Public Health. 2019;19:1–9.

CAS  Google Scholar 

Lateef F, Jamal S, Nasir S, Jamil Z. Invasive ductal carcinoma: correlation of immunophenotypic features with age. J Coll Physicians Surg Pakistan. 2017;27:18–22.

Google Scholar 

Malik SS, Baig M, Bilal Khan M, Masood N. Survival analysis of breast cancer patients with different treatments: A multicentric clinicopathological study. J Pak Med Assoc. 2019;69:976–80.

PubMed  Google Scholar 

Bjørge L, Hakulinen J, Vintermyr OK, Jarva H, Jensen TS, Iversen OE, et al. Ascitic complement system in ovarian cancer. Br J Cancer. 2005;92:895–905.

Article  PubMed  PubMed Central  Google Scholar 

Zhang T, Zhou H, Wang K, Wang X, Wang M, Zhao W, et al. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development. Biomed Pharmacother. 2022;147:112616. https://doi.org/10.1016/j.biopha.2022.112616

Article  CAS  PubMed  Google Scholar 

Saygin C, Wiechert A, Rao VS, Alluri R, Connor E, Thiagarajan PS et al. CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors. J Exp Med. 2017;214(9):2715–32.

Chakraborty A, Guha S. Granulocyte Colony-Stimulating factor/Granulocyte Colony-Stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells. Urology. 2007;69:1210–5.

Article  PubMed  Google Scholar 

Hirai K, Kumakiri M, Fujieda S, Sunaga H, Lao LM, Imamura Y, et al. Expression of granulocyte colony-stimulating factor and its receptor in epithelial skin tumors. J Dermatol Sci. 2001;25:179–88.

Article  CAS  PubMed  Google Scholar 

Salem AA, El Haty IA, Abdou IM, Mu Y. Interaction of human telomeric G-quadruplex DNA with thymoquinone: A possible mechanism for thymoquinone anticancer effect. Biochim Biophys Acta - Gen Subj; 2015.